Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma.

Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q38707661

about

Circular RNAs: emerging cancer biomarkers and targets.A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay.Circular RNAs: Biogenesis, Function, and a Role as Possible Cancer Biomarkers.microRNA expression profiles of scar and normal tissue from patients with posterior urethral stricture caused by pelvic fracture urethral distraction defects.CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7.[Circular RNA in Lung Cancer Research: Biogenesis, Functions and Roles].Circular RNAs function as ceRNAs to regulate and control human cancer progression.The Emerging Role of Circular RNAs in Hepatocellular Carcinoma.Prospect of Circular RNA in Hepatocellular Carcinoma: A Novel Potential Biomarker and Therapeutic Target Circular RNAs: Characteristics, Function and Clinical Significance in Hepatocellular Carcinoma

P2860

Q45130199-4E3F65C9-FED9-4E3C-8533-8FDDAA11B69C Q47980414-9440AA90-AEA1-4A57-8957-BA302A095DF6 Q48213837-B23B04F2-27A5-48A1-B777-D985E2059C50 Q50047884-0591A127-D9F6-401F-9FF7-8F76A826F0B9 Q52651215-E173C7DB-1230-4B9A-A3BE-6344C4734231 Q52708743-DF331D2C-6621-4232-9802-F722CED9BD91 Q53176299-ECA9DDD0-13CF-4EE8-B620-D3494B7D649C Q55404189-FF965479-AB73-425E-BF18-2C0CFDEB94FE Q58712750-510F2DB5-7DBF-4DBA-AE12-0A60D5F8D631 Q58802907-4B258CD4-DA01-4040-8635-2C60DB7B61C6

P2860

Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q38707661

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Hsa_circ_0005986 inhibits carc ...... for hepatocellular carcinoma.

@en

type

label

Hsa_circ_0005986 inhibits carc ...... for hepatocellular carcinoma.

@en

prefLabel

Hsa_circ_0005986 inhibits carc ...... for hepatocellular carcinoma.

@en

P1433

Q38707661-092EE76C-5303-4804-83AC-1AB1A8683077

P1476

Q38707661-1BFDF902-8919-47DC-ACA5-B864C3F2E6FF

P2093

Q38707661-496FBF7B-8847-406F-8A0F-EBEB86EB3A5A

Q38707661-6A7EF678-56C5-4ABB-AE70-BCC0C2D7A2F7

Q38707661-810A535B-5081-47EE-B1AB-22718FED809E

Q38707661-9893EB1A-71A4-4119-A882-7DE4870DEDB5

Q38707661-DDAAFE45-0CF1-40B3-96D1-F083E1D287FD

Q38707661-EF53B671-D3E4-4AB7-86F3-45E75F9395BC

Q38707661-F1997713-0123-4A3D-A373-74F68A0AB079

P2860

Q38707661-03DBC70F-1B3D-478E-ADA2-0CD26BA286FA

Q38707661-0680174F-0233-4E70-84E3-E25429602952

Q38707661-0905F09B-F84B-4EBA-B033-B2242AE425DD

Q38707661-135E6221-1F48-4E8C-BCD6-40CE0933C21C

Q38707661-18F1D135-493F-4A58-BF2B-E574F0789D86

Q38707661-1EC59084-8D6C-44B2-8283-9E0B2845F521

Q38707661-2C00FE88-B816-4494-AE93-8B6C1DBAEEAA

Q38707661-2ED202D8-A7EF-411A-9201-4890DD5F6F8B

Q38707661-3198D643-9603-41E6-BF90-F475B72C95F3

Q38707661-33572EAD-A528-44AC-B94A-94B8178C460B

P304

Q38707661-775B078C-DD8D-48A1-83B3-6F9484896251

P31

Q38707661-37C4EF0F-1E1C-415E-85DB-6C993FE23DBE

P356

Q38707661-41E5B163-1A47-48AA-96F8-0A10E38C8226

P407

Q38707661-E3675A9C-5B71-4685-B698-81B8B3C66183

P433

Q38707661-39B50371-F240-4137-BE09-AC8E35D2FE8E

P478

Q38707661-93802435-7FBB-4EE9-9CC5-5BE6BE7A8B1E

P577

Q38707661-8E45DB91-DC36-4D0B-B750-7860D0B2E68C

P698

Q38707661-0322B237-98FA-4AD2-8722-D392714F2D08

P921

Q38707661-F7CF40B8-7E53-4AD9-B928-0A41C00C0E26

P932

Q38707661-A5C9E40D-FCB3-433F-8D96-3AC157671958

P356

ONCOTARGET.16709

P1433

P1476

Hsa_circ_0005986 inhibits carc ...... for hepatocellular carcinoma.

@en

P2093

Junming Guo

http://www.w3.org/2001/XMLSchema#string

Liyun Fu

http://www.w3.org/2001/XMLSchema#string

Qingqing Chen

http://www.w3.org/2001/XMLSchema#string

Sheng Ying

http://www.w3.org/2001/XMLSchema#string

Tianwen Li

http://www.w3.org/2001/XMLSchema#string

Ting Yao

http://www.w3.org/2001/XMLSchema#string

Yaoren Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types

Expanded identification and characterization of mammalian circular RNAs

Molecular mechanisms of long noncoding RNAs on gastric cancer

Competing endogenous RNA: the key to posttranscriptional regulation

Circular RNAs: analysis, expression and potential functions

High-throughput data integration of RNA-miRNA-circRNA reveals novel insights into mechanisms of benzo[a]pyrene-induced carcinogenicity

Circular RNAs are a large class of animal RNAs with regulatory potency

Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.

Circular RNA participates in the carcinogenesis and the malignant behavior of cancer.

Global circular RNA expression profile of human gastric cancer and its clinical significance.

P304

43878-43888

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16709

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28410211

http://www.w3.org/2001/XMLSchema#string

P921

P932

5546447

http://www.w3.org/2001/XMLSchema#string